EP2853274A1 — Compositions and methods for treating diseases of the nail
Assigned to Dow Pharmaceutical Sciences Inc · Expires 2015-04-01 · 11y expired
What this patent protects
Methods and compositions for treating disorders of the nail and nail bed. Such compositions do not form a film upon application to the surface of the nail and contain a vehicle in which all components of the compositions are dissolved, suspended, dispersed, or emulsified, a non-v…
USPTO Abstract
Methods and compositions for treating disorders of the nail and nail bed. Such compositions do not form a film upon application to the surface of the nail and contain a vehicle in which all components of the compositions are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, and which composition is effective in treating a disorder of the nail or nail bed.
Drugs covered by this patent
- Jublia (EFINACONAZOLE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.